SCHEMBL19683023

SCHEMBL19683023

CN(CCCC1CC2CCCC(C2)C1)Cc1ccc(/C=C/C(=O)Nc2ccccc2N)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 15/20 0.49
▸ HDAC2 Q92769 6/20 0.48
▸ KDM1A O60341 2/20 0.48
▸ MAOA P21397 2/20 0.48
▸ HDAC4 P56524 3/20 0.46
▸ HDAC3 O15379 2/20 0.46
▸ HDAC10 Q969S8 2/20 0.46
▸ HDAC8 Q9BY41 2/20 0.46
▸ HDAC6 Q9UBN7 2/20 0.46
▸ HDAC5 Q9UQL6 2/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46
▸ EP300 Q09472 1/20 0.44
▸ MEF2D Q14814 1/20 0.44
▸ RARB P10826 1/20 0.44
▸ MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17483936 0.89 HDAC1 (0.54) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL19683181 0.81 HDAC1 (0.56) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL19683024 0.81 HDAC1 (0.52) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL17483899 0.80 HDAC1 (0.55) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL17483929 0.79 HDAC1 (0.50) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL19666050 0.79 HDAC1 (0.71) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL19683022 0.79 HDAC1 (0.71) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL17478531 0.79 HDAC1 (0.71) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL17478501 0.79 HDAC1 (0.71) HDAC1HDAC2KDM1AMAOAHDAC4
SCHEMBL17483901 0.78 HDAC1 (0.57) HDAC1HDAC2KDM1AMAOAHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349540-A1 HISTONE DEACETYLASE INHIBITORS THE GENERAL HOSPITAL CORPORATION 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349540-A1 HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HDAC5 HDAC1 1/4885HDAC2 4/4885KDM1A 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback